YSYun Sun

Yun Sun

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yun Sun has a total of 36 co-authors. Here are the top co-authors by number of shared publications:

  • Feng Huang

    College of Pharmaceutical Science, Yunnan University of Chinese Medicine, Kunming 650500, People's Republic of China; School of Chinese Materia Medica and Yunnan Key Laboratory of Southern Medicinal Utilization, Yunnan University of Chinese Medicine, Kunming 650500, People's Republic of China

    2 shared publications
  • Lu Qu

    School of Pharmaceutical Science, Department of Pharmacology of Traditional Chinese Medicine, Yunnan University of Traditional Chinese Medicine, Kunming 650500, China

    2 shared publications
  • Yuping Lin

    School of Chinese Materia Medica &Yunnan Key Laboratory of Southern Medicine Utilization, Yunnan University of Chinese Medicine, Kunming 650500, PR China

    2 shared publications
  • Chenghong Du

    School of Chinese Materia Medica &Yunnan Key Laboratory of Southern Medicine Utilization, Yunnan University of Chinese Medicine, Kunming 650500, China

    1 shared publication
  • Chunyan Hu

    School of Chinese Materia Medica &Yunnan Key Laboratory of Southern Medicine Utilization, Yunnan University of Chinese Medicine, Kunming 650500, China

    1 shared publication
  • Feng Huang

    1 shared publication

Latest Publications

  • Cu(OAc)2/Vasicine-Catalyzed C–O Coupling of 2-Iodoanilides With MeOH

    by Wenxia Du, Meiling Li, Jinlong Xie, Wenhong Suo, Zewei Mao, Yun Sun

    The metal-catalyzed functionalization of o-haloanilides has become a popular research topic. In the present work, we have explored a practical Cu/vasicine-catalyzed Ullmann-type C–O coupling methodology of 2-iodoanilides with MeOH, which could regioselectively form 2-methoxylanilides.

  • Cang-ai volatile oil ameliorates imiquimod-induced psoriatic skin lesions by suppressing the ILC3s

    by Yuping Lin, Xunqing Yin, Shan Ma, Yongmei Xue, Chunyan Hu, Yuhuan Xie, Yongcheng Zeng, Xiujuan Zhao, Chenghong Du, Yun Sun, et al.


  • Daphnetin contributes to allergen-induced Th2 cytokine expression and type 2-immune responses in atopic dermatitis and asthma

    by Yi Zhang, Lu Qu, Yun Sun, YuPing Lin, Jing Zeng, LiXia He, Xiucun Li, Wen Gu, Jian Nie, Xiaoling Yu, et al.

    Daphne koreana Nakai is a cherished medicinal plant in the Changbai Mountain region of China. It can be incorporated into medicinal meals and used for various skin diseases by infiltrating liquor. Daphnetin (7,8-dihydroxycoumarin, Dap.) is a main constituent of D. koreana Nakai, which has been used to treat inflammatory conditions and immune disorders due to its numerous pharmacological activities, including anti-oxidant, anti-inflammatory, analgesic, etc. Atopic dermatitis (AD) and allergic asthma are typical diseases of type 2-immune responses. In the present study, the therapeutic potential of Dap. against AD and allergic asthma was investigated using animal and cell experiments. AD-like lesions were induced by repeated application of 1-chloro-2,4-dinitrobenzene (DNCB) to the shaved dorsal skin of BALB/c mice. Ovalbumin (OVA) induction was utilized to establish a mouse asthma model. A passive cutaneous anaphylaxis (PCA) mouse ear model and immunoglobulin E (IgE)/bovine serum albumin (BSA)-stimulated RBL-2H3 cells were used for in vitro assays. The skin lesions and serum and tissue homogenates of the mice were analyzed using histological analysis, immunohistochemistry (IHC) and enzyme-linked immunosorbent assay (ELISA), respectively, in order to investigate the anti-AD effects of Dap. Histological analysis was performed on the allergic asthma model to observe inflammatory cell infiltration in the lung tissues. Total IgE and OVA-specific IgE in the serum were measured by ELISA. The levels of inflammatory cytokines in BALF were detected by ELISA. In addition, ELISA and western blotting were performed for the in vitro analysis of RBL-2H3 cells. The results showed that Dap. inhibited the development of DNCB-induced AD-like lesions in the BALB/c mice by reducing the severity of the lesions, epidermal thickness and mast cell infiltration; this was accompanied by reduced levels of IgE and inflammatory cytokines [interleukin (IL)-4, IL-5, IL-9, IL-13, IL-33 and thymic stromal lymphopoietin (TSLP)]. In the allergic asthma model, Dap. reduced the number of infiltrated inflammatory cells in the lung tissues. Moreover, the levels of total serum IgE and OVA-specific IgE were reduced in the high daphnetin dose groups (Dap., −100 mg kg−1). Dap. administered at a dose of −100 mg kg−1 decreased the levels of inflammatory cytokines (IL-4, IL-5, IL-9, IL-13, IL-33 and TSLP in BALF). Furthermore, Dap. administered to IgE-sensitized mice effectively attenuated the IgE-triggered PCA reaction. In vitro, Dap. decreased the expression levels of histamine, IL-4, IL-6, IL-13, MIP-1α and INF-α, and reduced the protein expression levels of phosphorylated MAPKs, P-Lyn and P-syk in the RBL-2H3 cells. Therefore, Dap. can be represented as a potential therapeutic strategy for the treatment of allergic inflammatory conditions via immunoregulation.


  • Copper-catalyzed regioselective 2-amination of o-haloanilides with aqueous ammonia

    by Yan-Ling Tang, Mei-Ling Li, Jin-Chun Gao, Yun Sun, Lu Qu, Feng Huang, Ze-Wei Mao


  • Three New Pregnane Alkaloids from Veratrum taliense

    by Yun Sun, Jin‐Xiong Chen, Lin Zhou, Jia Su, Yan Li, Ming‐Hua Qiu

    Three new alkaloids, 3‐O‐acetylveralkamine (1), veralkamine 3‐(β‐D‐glucopyranoside) (2), and 6,7‐epoxyverdine (3), together with five known alkaloids, veramitaline, veralkamine (4), angeloylzygadenine, veratroylzygadenine, and veramiline 3‐(β‐D‐glucopyranoside), were isolated from the whole plants of Veratrum taliense. Their structures were elucidated on the basis of spectroscopic analysis, and the NMR data of veralkamine (4) are given for the first time. In addition, the cytotoxic activities of all isolated compounds, except for veramitaline, were tested.